Hereditary tyrosinemia type 1 (HT1) is caused by the lack of fumarylacetoacetate hydrolase (FAH), the last enzyme of the tyrosine catabolic pathway. Up to now, around 100 mutations in the FAH gene have been associated with HT1, and despite many efforts, no clear correlation between genotype and clinical phenotype has been reported. At first, it seems that any mutation in the gene results in HT1. However, placing these mutations in their molecular context allows a better understanding of their possible effects. This chapter presents a closer look at the FAH gene and its corresponding protein in addition to provide a complete record of all the reported mutations causing HT1.
CITATION STYLE
Morrow, G., Angileri, F., & Tanguay, R. M. (2017). Molecular aspects of the FAH mutations involved in HT1 disease. In Advances in Experimental Medicine and Biology (Vol. 959, pp. 25–48). Springer New York LLC. https://doi.org/10.1007/978-3-319-55780-9_3
Mendeley helps you to discover research relevant for your work.